Correspondence 0001193125-25-015903 from Foghorn Therapeutics Inc. (FHTX) (CIK 0001822462) (FHTX)
Foghorn Therapeutics Inc. (FHTX) (CIK 0001822462)
Date: Jan. 29, 2025 · CIK: 0001822462 · Accession: 0001193125-25-015903
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284476
Letter
Foghorn Therapeutics Inc.
500 Technology Square, Suite 700
Cambridge, MA 02139
January 29, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Attention:
Joshua Gorsky
Re:
Foghorn Therapeutics Inc.
Registration Statement on Form S-3 (File No. 333-284476)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Foghorn Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on January 31, 2025, or as soon as possible thereafter. The Company hereby authorizes Rachel Phillips of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please contact Rachel Phillips (Rachel.Phillips@ropesgray.com) / telephone: 212-841-8857 of Ropes & Gray LLP as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
FOGHORN THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Foghorn Therapeutics Inc. 500 Technology Square, Suite 700 Cambridge, MA 02139 January 29, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Foghorn Therapeutics Inc. Registration Statement on Form S-3 (File No. 333-284476) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Foghorn Therapeutics Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on January 31, 2025, or as soon as possible thereafter. The Company hereby authorizes Rachel Phillips of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact Rachel Phillips (Rachel.Phillips@ropesgray.com) / telephone: 212-841-8857 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, FOGHORN THERAPEUTICS, INC. By: /s/ Kristian Humer Name: Kristian Humer Title: Chief Financial Officer [Signature Page to Acceleration Request]